Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ménocia is a hormone-free and phytoestrogen-free dietary supplement developed by Laboratoire CCD (Laboratoire de la Femme) to support women during menopause and perimenopause. The formulation contains a blend of natural active ingredients, including ashwagandha extract, saffron extract, vitamin B6, and vitamin B9 (folic acid). It is specifically designed to alleviate common menopausal symptoms such as hot flashes, night sweats, and fatigue, while also promoting emotional balance and psychological well-being. Administered orally in capsule form, Ménocia is suitable for vegetarians and vegans and is manufactured without preservatives, nanoparticles, or ingredients of animal origin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ménocia.